Literature DB >> 20829213

Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study.

Andrea Barbieri1, Francesca Bursi, Francesco Grigioni, Christophe Tribouilloy, Jean Francois Avierinos, Hector I Michelena, Dan Rusinaru, Catherine Szymansky, Antonio Russo, Rakesh Suri, Maria Letizia Bacchi Reggiani, Angelo Branzi, Maria Grazia Modena, Maurice Enriquez-Sarano.   

Abstract

AIMS: To determine the frequency, predictors, and outcome implications of pulmonary hypertension (PH) diagnosed by Doppler echocardiography in a large cohort of patients with the homogenous diagnosis of degenerative mitral regurgitation (MR) due to flail leaflets. METHODS AND
RESULTS: The Mitral Regurgitation International DAtabase (MIDA) is a registry including patients with MR due to flail leaflets consecutively referred at tertiary centres in Europe and the USA. Between 1987 and 2004, pulmonary artery systolic pressure (PASP) was measured at baseline by Doppler echocardiography in 437 patients (age 67 ± 11 years; 66% men). Pulmonary hypertension (PASP > 50 mmHg) was observed in 102 patients (23%). Independent predictors of PH were age and left atrial size (P < 0.0001). During a mean follow-up of 4.8 ± 2.8 years, PH was a strong independent predictor of death [adjusted HR 2.03 (1.30-3.18) P = 0.002], cardiovascular death [CVD; adjusted HR 2.21 (1.30-3.76) P = 0.003], and heart failure [adjusted HR 1.70 (1.10-2.62) P = 0.018]. Mitral valve surgery at any time during follow-up (performed in 325 patients, 75%) was beneficial [adjusted HR for death 0.22 (0.14-0.36) P < 0.001], but PH was associated with the increased risk of postoperative death and CVD (P = 0.01).
CONCLUSION: Pulmonary hypertension is a frequent complication of significant MR due to flail leaflet and is associated with major outcome implications, approximately doubling the risk of death and heart failure after diagnosis. Mitral valve surgery performed during follow-up is beneficial but does not completely abolish the adverse effects of PH once it is established and is particularly beneficial in patients without PH. These data support relieving PH secondary to MR due to flail leaflet, but also careful consideration for mitral surgery before PH is established.

Entities:  

Mesh:

Year:  2010        PMID: 20829213     DOI: 10.1093/eurheartj/ehq294

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  38 in total

1.  Initial misdiagnosis of acute flail mitral valve is not infrequent: The role of echocardiography.

Authors:  Li Zhou; Michael Grushko; James M Tauras; Cynthia C Taub
Journal:  J Cardiovasc Dis Res       Date:  2013-06-18

2.  Pulmonary hypertension: a long-term risk stratifier in primary mitral regurgitation.

Authors:  Mi-Jeong Kim; Hae Ok Jung
Journal:  Ann Transl Med       Date:  2016-12

3.  Is pulmonary artery pressure a trigger of adverse outcome in mitral regurgitation?

Authors:  Iside Scarfò; Giovanni La Canna
Journal:  Ann Transl Med       Date:  2016-12

Review 4.  Treatment and management of mitral regurgitation.

Authors:  Michele De Bonis; Francesco Maisano; Giovanni La Canna; Ottavio Alfieri
Journal:  Nat Rev Cardiol       Date:  2011-11-22       Impact factor: 32.419

5.  New Diagnostic and Therapeutic Strategies for Pulmonary Hypertension Associated with Left Heart Disease.

Authors:  Scott Feitell; Miriam Jacob
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-03

Review 6.  Epidemiology of pulmonary hypertension and right ventricular failure in left heart failure.

Authors:  Thenappan Thenappan; Mardi Gomberg-Maitland
Journal:  Curr Heart Fail Rep       Date:  2014-12

Review 7.  Degenerative Mitral Regurgitation: Assessment, Physical Examination, and Imaging.

Authors:  Nina C Wunderlich; Roy Beigel; Florian Rader; Jennifer Franke; Robert J Siegel
Journal:  Curr Cardiol Rep       Date:  2019-07-22       Impact factor: 2.931

8.  Management of severe pulmonary hypertension in patients undergoing mitral valve surgery.

Authors:  Carlos D Davila; Paul R Forfia
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-06

9.  The impact of preoperative and postoperative pulmonary hypertension on long-term surgical outcome after mitral valve repair for degenerative mitral regurgitation.

Authors:  Takashi Murashita; Yukikatsu Okada; Hideo Kanemitsu; Naoto Fukunaga; Yasunobu Konishi; Ken Nakamura; Tadaaki Koyama
Journal:  Ann Thorac Cardiovasc Surg       Date:  2014-04-18       Impact factor: 1.520

Review 10.  Pulmonary Hypertension in Patients Eligible for Transcatheter Mitral Valve Repair: Prognostic Impact and Clinical Implications.

Authors:  Evin Yucel; Rasha Al-Bawardy; Philippe B Bertrand
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.